Madrigal Pharmaceuticals (MDGL) Stock Analysis: AI Score & Alternative Data
MDGL alt-data: revenue climbing, web traffic lagging
Is Madrigal Pharmaceuticals a buy right now? The alternative data says hold. This MDGL stock analysis is built on the 25+ alternative data signals AltIndex tracks on Madrigal Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 56/100: a Hold. The stock trades at $499.65 with a $11B market cap.
The bullish side of the 90-day ledger: revenue up 71.4% YoY to $360M, job postings up 23.9% to 83 open roles, and headcount (according to LinkedIn) up 9.2% to 1K employees. The drag: web traffic down 48.3% to 58K monthly visits. That tension is what keeps the score mid-range.
MDGL’s broader alt-data profile also covers business outlook (77% of employees positive), X followers (2K), and sentiment (100/100). Every signal links to its own page with full history, the MDGL technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on MDGL is just below.
Madrigal Pharmaceuticals AI Stock Analysis
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the development of novel therapies for cardiovascular, metabolic, and liver diseases. The company's primary focus is on non-alcoholic steatohepatitis (NASH), a condition with high unmet medical need.
Analysis generated October 5, 2026.
Recent Madrigal Pharmaceuticals Stock Alerts
|
Madrigal Pharmaceuticals | September 17 Web Traffic is down by 38.5% over the last month. |
|
Madrigal Pharmaceuticals | August 26 Price is up by 7% in the last 24h. |
|
Madrigal Pharmaceuticals | August 11 Over the past few months, there has been an downward trend in Web Traffic. |
|
Madrigal Pharmaceuticals | August 4 Price is up by 6% in the last 24h. |
Madrigal Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 58K | 48.3% | |
| Job Posts | 83 | 23.9% | |
| LinkedIn Employees | 1K | 9.2% | |
| Employee Recommend | 78 | 0% | |
| Business Outlook | 77 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 15 | 200.0% | |
| Stocktwits Mentions | 5 | 80.8% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 7K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 2K | 0.9% | |
| Facebook Followers | 74 | 7.2% | |
| Facebook Engagement | 0 | N/A |
About Madrigal Pharmaceuticals (MDGL)
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States.
| Price | $499.65 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $11B |
| Year Range | $412 – $603 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Madrigal Pharmaceuticals News
View more → |
Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You?September 10 - Biztoc.com |
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth ConferenceAugust 6 - GlobeNewswire |
|
Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate UpdatesJuly 30 - GlobeNewswire |
|
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)July 6 - GlobeNewswire |
See Madrigal Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for MDGL, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEMadrigal Pharmaceuticals Earnings & Financial Performance
View all earnings →Madrigal Pharmaceuticals Insider Trading Activity
View all →| Sibold William John filed to sell 202,907 shares at $0.0. Sep 11 '26 |
| Sibold William John filed to sell 202,801 shares at $0.0. Sep 11 '26 |
| Sibold William John filed to sell 197,746 shares at $0.0. Sep 11 '26 |
| Sibold William John filed to sell 202,423 shares at $0.0. Sep 11 '26 |
| Sibold William John filed to sell 202,583 shares at $0.0. Sep 11 '26 |
Madrigal Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Daniel S. Goldman |
May 19, 23 | Sell | $8K+ |
Stocks Similar to Madrigal Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Bio-TechneTECH |
$72.53 0.1% | $11B | 28 |
 |
Biomarin PharmaceuticalBMRN |
$55.58 1.1% | $11B | 48 |
 |
10X GenomicsTXG |
$78.72 2.4% | $11B | 41 |
 |
AvantorAVTR |
$15.41 0.1% | $10B | 48 |
 |
Halozyme TherapeuticsHALO |
$111.91 2.0% | $12B | 67 |
Explore Madrigal Pharmaceuticals Data
Frequently Asked Questions: Madrigal Pharmaceuticals (MDGL)
Madrigal Pharmaceuticals has an AltIndex AI Score of 56/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
56/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Madrigal Pharmaceuticals (MDGL) stock is $499.65 with a market cap of $11B.
As of today, Madrigal Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Madrigal Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Madrigal Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The MDGL stock price chart above shows Madrigal Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Madrigal Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Madrigal Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
